Aviva PLC Atri Cure, Inc. Transaction History

Aviva PLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 10, 2021	SELL	$64.13 - $80.18 $1.25 Million - $1.56 Million	-19,430 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$53.79 - $66.98 $690,556 - $859,889	-12,838 Reduced 39.79%	19,430 $1.27 Million
Q4 2020 Feb 10, 2021	SELL	$34.56 - $57.55 $904,124 - $1.51 Million	-26,161 Reduced 44.77%	32,268 $1.8 Million
Q3 2020 Nov 12, 2020	BUY	$38.36 - $46.91 $272,356 - $333,061	7,100 Added 13.83%	58,429 $2.33 Million
Q2 2020 Aug 13, 2020	SELL	$31.78 - $51.19 $2.13 Million - $3.43 Million	-67,097 Reduced 56.66%	51,329 $2.31 Million
Q1 2020 May 14, 2020	BUY	$24.49 - $43.84 $2.9 Million - $5.19 Million	118,426 New	118,426 $3.98 Million

212

49.7M

12K

7.2K

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.66B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

Get notified when there are updates to the investment portfolio of Aviva PLC, based on Form 13F filings with the SEC.

Stay updated on Aviva PLC with notifications on news.